---
title: "Understanding the Market | ALPHAMAB-B rose over 7% after announcing plans for an on-market share buyback, with the market focusing on the significant data from the ESMO conference"
description: "ALPHAMAB-B rose over 7%, as of the time of writing, it increased by 6.79%, trading at HKD 14.63, with a transaction volume of HKD 37.113 million. In terms of news, ALPHAMAB announced that on October 1"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/261538337.md"
published_at: "2025-10-17T02:26:03.000Z"
---

# Understanding the Market | ALPHAMAB-B rose over 7% after announcing plans for an on-market share buyback, with the market focusing on the significant data from the ESMO conference

> ALPHAMAB-B rose over 7%, as of the time of writing, it increased by 6.79%, trading at HKD 14.63, with a transaction volume of HKD 37.113 million. In terms of news, ALPHAMAB announced that on October 16, the company spent HKD 5.483 million to repurchase 400,000 shares. The company previously announced that, based on the general authorization granted to the board (share repurchase authorization approved by shareholders at the annual general meeting on June 12, 2025), the board resolved on October 12, 2025, to repurchase the company's ordinary shares from the open market from time to time, with a maximum repurchase amount of HKD 20 million. In addition, the 2025 European Society for Medical Oncology (ESMO) will be held in Berlin, Germany, from October 17 to 21, and the latest research abstracts will be announced on the day of the presentation. It is reported that 23 studies from China have been selected for LBA, including key studies such as ALPHAMAB's KN026

According to the Zhitong Finance APP, ALPHAMAB-B (09966) rose over 7%, and as of the time of writing, it was up 6.79%, priced at HKD 14.63, with a transaction volume of HKD 37.113 million.

In terms of news, ALPHAMAB-B announced that on October 16, the company spent HKD 5.483 million to repurchase 400,000 shares. The company previously announced that, based on the general authorization granted to the directors (share repurchase authorization, approved by shareholders at the annual general meeting on June 12, 2025), the board of directors resolved on October 12, 2025, to periodically repurchase the company's ordinary shares from the open market, with a maximum repurchase amount of HKD 20 million.

Additionally, the 2025 European Society for Medical Oncology (ESMO) will be held from October 17 to 21 in Berlin, Germany, with the latest research abstracts to be announced on the day of the presentations. It is reported that 23 studies from China have been selected for LBA, including key studies such as ALPHAMAB's KN026

### Related Stocks

- [09966.HK - ALPHAMAB-B](https://longbridge.com/en/quote/09966.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 康寧傑瑞製藥-B 在香港交易所披露以 483 萬港元回購 50 萬股股票 | 阿爾法瑪癌症公司已披露回購 50 萬股，總金額為 4,833,510 港元，已向香港證券交易所報告。這些股份將作為庫存股持有 | [Link](https://longbridge.com/en/news/271193146.md) |
| 婚姻題材劇《黃信》獲得柏林電影節最高獎項 | 《黃字母》是一部關於在政治壓力下婚姻的土耳其語劇集，獲得了柏林電影節金熊獎。影片由奧茲古·納馬爾和坦蘇·比切爾主演，講述了一對夫婦在丈夫因在線批評而遭到土耳其國家打壓後，被迫離開舒適生活的故事。導演伊爾克·查塔克強調，真正的威脅來自獨裁者和 | [Link](https://longbridge.com/en/news/276519104.md) |
| 'Hamnet'的作曲家 Max Richter 在柏林電影節的相機頒獎儀式上受到表彰 | 英國作曲家馬克斯·裏希特在柏林電影節上因其對電影製作的重要貢獻獲得了柏林銀熊獎。奧斯卡獲獎導演趙婷讚揚了他的音樂，稱其能夠喚起深刻的情感。裏希特為電影《哈姆奈特》創作的配樂使他獲得了首個奧斯卡提名，該片總共獲得了八項提名。裏希特以其在《與巴 | [Link](https://longbridge.com/en/news/276266530.md) |
| 約翰·特託羅在《紐約唯一活着的小偷》中飾演一位年邁的小偷，擁抱模擬技術 | 約翰·圖爾特羅主演的《紐約唯一的活扒手》是一部關於一名年邁扒手在技術變革中掙扎的電影。該片在聖丹斯電影節首映，並在柏林特別展映中亮相，探討了數字時代適應與人際互動的主題。圖爾特羅飾演的角色以一名富有的 Z 世代個體為目標，突顯了代際差異。該 | [Link](https://longbridge.com/en/news/276475534.md) |
| 澳大利亞西部電影《Wolfram》在柏林電影節上重新詮釋了土著人的敍事 | 澳大利亞導演沃裏克·桑頓的新片《沃爾夫拉姆》在柏林電影節首映，突顯了土著敍事在電影中的重要性。桑頓強調了從殖民者手中重新奪回講故事權的重要性，並表示媒體的接入使土著聲音得以被聽見。《沃爾夫拉姆》設定在 1930 年代，講述了兩個孩子逃離礦工 | [Link](https://longbridge.com/en/news/276151665.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.